Johnson & Johnson (JNJ) Stake Increased by RNC Capital Management LLC

Marco Green
December 17, 2017

Apg Asset Management Nv sold 1.17M shares as the company's stock rose 6.85% with the market. The Annex Advisory Services Llc holds 8,794 shares with $1.16 million value, up from 3,118 last quarter. Johnson & Johnson now has $382.72 billion valuation. From the opening price, the stock has seen a change of -0.01% recently clocking in with a price of $142.46. The company had a trading volume of 12,516,980 shares, compared to its average volume of 5,120,258. Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, April 18th. It has underperformed by 4.16% the S&P500.

Quantum Capital Management, which manages about $700.30M and $405.89M US Long portfolio, upped its stake in Eagle Materials Inc (NYSE:EXP) by 11,864 shares to 65,271 shares, valued at $6.03 million in 2017Q2, according to the filing. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since December 16, 2016 and is uptrending. Moreover, First Light Asset Management Llc has 2.11% invested in the company for 754,560 shares. The stock increased 2.58% or $9.31 during the last trading session, reaching $369.87. About 940,984 shares traded or 441.10% up from the average. It has outperformed by 39.76% the S&P500.

Investors sentiment is 0.83 in 2017 Q2. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. It is negative, as 50 investors sold JNJ shares while 878 reduced holdings. 123 funds opened positions while 564 raised stakes. Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson by 0.4% in the 2nd quarter. Tukman Grossman Capital Mgmt Incorporated has 7.41% invested in Johnson & Johnson (NYSE:JNJ). Northstar Invest Advisors Limited Liability Com holds 2.6% or 97,452 shares. New York-based Horizon Kinetics Limited Co has invested 0.1% in Johnson & Johnson (NYSE:JNJ). (NYSE:V). Integral Derivatives Limited Liability Company holds 0.02% of its portfolio in Visa Inc. 3,015 are owned by Hillsdale Inv. Tru Com Of Oklahoma reported 8,016 shares stake. Norges Bank purchased a new position in shares of Johnson & Johnson during the fourth quarter valued at about $3,220,322,000. Whitnell, Illinois-based fund reported 27,815 shares. Hourglass Capital Ltd Liability Corporation reported 22,603 shares. Wedge Cap Management L Limited Partnership Nc holds 298,932 shares. Washington Capital Mngmt holds 0.32% or 2,180 shares. Boltwood Capital Mgmt owns 13,125 shares or 1.17% of their U.S. portfolio. Blue Chip Partners Inc who had been investing in Travelers Companies Inc for a number of months, seems to be less bullish one the $36.92 billion market cap company.

Analysts await Intuitive Surgical, Inc.

JNJ has been the topic of a number of research analyst reports. After $1.90 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47 % negative EPS growth. State Street Corp increased its stake in shares of Johnson & Johnson by 4.3% during the first quarter. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2017/12/16/johnson-johnson-jnj-stake-increased-by-rnc-capital-management-llc.html. It also increased its holding in Vanguard Scottsdale Fds (VCIT) by 17,479 shares in the quarter, for a total of 331,268 shares, and has risen its stake in Exxon Mobil Corp (NYSE:XOM). The current consensus recommendation provided by covering analysts is 2.40. The firm has "Buy" rating by BMO Capital Markets given on Tuesday, July 18. Therefore 25% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has "Sell" rating given on Wednesday, September 20 by Goldman Sachs. The stock has "Hold" rating by Stifel Nicolaus on Tuesday, July 18. Jefferies Group raised Johnson & Johnson from a "hold" rating to a "buy" rating and boosted their price target for the company from $145.00 to $157.00 in a report on Wednesday, October 11th. The company has a market capitalization of $356.37 billion, a P/E ratio of 22.24 and a beta of 0.81. Cowen set a $147.00 price target on Johnson & Johnson and gave the stock a "buy" rating in a research note on Thursday, August 24th. The stock of The Travelers Companies, Inc.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Forbes.com which released: "The Outlook For Johnson & Johnson's Immunology Drug Business" on December 05, 2017, also Fool.com with their article: "Dividend stats on Johnson & Johnson" published on December 09, 2017, Seekingalpha.com published: "Johnson & Johnson (JNJ) Management Presents at Citi Global Healthcare Conference" on December 07, 2017. RBC Capital Markets maintained the shares of JNJ in report on Wednesday, July 20 with "Outperform" rating.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER